Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
boston top stories
cannabis
cholesterol
clinical trials
data
inclisiran
ipo
ldl
life sciences
mark timney
mt sinai hospital
national blog main
national top stories
new york
new york blog main
new york top stories
pcsk9
peter wijngaard
praluent
prashant vaishnava
privateer holdings
regeneron pharmaceuticals
repatha
san francisco blog main
san francisco top stories
sanofi
tc
the medicines co.
What
nasdaq
2
×
year
2
×
aces
announced
apiece
based
big
british
cannabis
ceo
cholesterol
closing
columbia
company
drug
flexible
governments
high
inclisiran
ipo
key
lowering
marijuana
meant
medco
medical
medicine
medicines
million
old
open
passed
patients
pharmacies
priced
pricing
products
public
researchers
saw
Language
unset
Current search:
nasdaq
×
year
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@techcrunch.com
5 years ago
Public shareholders got high today on Tilray, the first marijuana company to IPO on Nasdaq
